[Treatment of chronic viral hepatitis B with lamivudine].

C. Buffet,G. Perlemuter
2001-01-27
Presse Medicale
Abstract:UNLABELLED INTERFERON ALPHA AND LAMIVUDINE: Chronic hepatitis B is currently treated with interferon alpha and lamivudine. Lamivudine (marketed under the name Zeffix in France) is given in oral preparations and is excreted in the urine. It is rapidly effective against virus replication since, after a one-month treatment, hepatitis B DNA levels are negative in most of the treated patients. After 12 months, there is an improvement in liver histology. ADVANTAGES AND DISADVANTAGES The probability of effective treatment is greatest for patients with highly elevated transaminase levels and low hepatitis B DNA levels prior to treatment. Another advantage of lamivudine is the extremely low rate of side effects. The risk of a rebound in viral replication after withdrawal is a drawback together with the possible development of viral mutations of the polymerase gene, particularly after more than one year of treatment. INDICATIONS Lamivudine can be prescribed for patients with a contraindication or non-responsive to alpha interferon: liver transplantation candidates, organ graft recipients. For other cases, alpha interferon is the first line treatment of choice. If lamivudine is used too early, there is a risk the patients could no longer be transplanted after the development of mutations and major aggravation of liver function. Future perspectives include simultaneous or sequential use of antiviral agents.
What problem does this paper attempt to address?
This paper attempts to solve the problems of the internal structure and dynamical characteristics of the Milky Way, especially to construct a dynamical model of the inner region of the Milky Way that can explain the observational data. Specifically, the main problems faced by the researchers include: 1. **Reconstructing the mass density distribution in the inner region of the Milky Way**: Using the infrared data of the COBE satellite, the three - dimensional mass density distribution obtained by the back - projection method (Binney, Gerhard & Spergel 1997) requires a dynamical model to verify whether these density distributions are reasonable. 2. **Reproducing the observed dynamical features**: The model needs to be able to reproduce the observed kinematic data in three specific windows (Baade's Window and two off - axis regions), including line - of - sight velocities, velocity dispersions, and available proper - motion data. 3. **Handling the orbital combinations of classical and non - classical integrals**: In order to describe the dynamical characteristics of the Milky Way more accurately, the researchers extended Schwarzschild's method, so that the distribution function (DF) depending on classical integrals can be combined with orbits respecting non - classical integrals. This method allows the use of Schwarzschild's orbits to represent the differences between the real Milky Way DF and the approximate classical DF. 4. **Determining the parameters of the bar - like structure**: The model assumes that the viewing angle from the Sun to the long axis of the bar - like structure is 20°, and the pattern speed of the bar is 60 km/s/kpc, and attempts to constrain these parameters by fitting the observational data. 5. **Evaluating the gravitational microlensing effect**: The model is also used to predict the gravitational microlensing optical depth to test the contributions of different stellar populations to microlensing events. Through the solution of these problems, the researchers hope to better understand the structure and dynamical characteristics of the inner region of the Milky Way and provide a theoretical basis for future observations.